Whether these alterations in the spatial landscape of the malignant mesothelioma TIME contribute, at least partially, to the generally more favorable prognosis of MPM than MPeM, or the improved survival prospects of patients with BAP1 alterations alone among MPM cases, remains a topic for future research. Here, BAP1 is linked to malignant mesothelioma.